Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #301 to #550.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Protective action guide‏‎ (2 revisions)
  2. Radiation worker‏‎ (2 revisions)
  3. Detriment‏‎ (2 revisions)
  4. Dose-rate effect‏‎ (2 revisions)
  5. Inclusiveness‏‎ (2 revisions)
  6. Source-related‏‎ (2 revisions)
  7. Internal conversion electron‏‎ (2 revisions)
  8. Electron-capture decay‏‎ (2 revisions)
  9. LD 50/30‏‎ (2 revisions)
  10. Telangiectasia‏‎ (2 revisions)
  11. Track structure‏‎ (2 revisions)
  12. Mendelian diseases‏‎ (2 revisions)
  13. Accreditation‏‎ (2 revisions)
  14. Neurological syndrome‏‎ (2 revisions)
  15. Genomic integrity‏‎ (2 revisions)
  16. Occupational exposure‏‎ (2 revisions)
  17. Hazard‏‎ (2 revisions)
  18. Peak skin dose‏‎ (2 revisions)
  19. Bragg peak‏‎ (2 revisions)
  20. Radioactive dispersion device‏‎ (2 revisions)
  21. Radon: Units of Measure‏‎ (2 revisions)
  22. Coronary heart disease‏‎ (2 revisions)
  23. Reference air kerma‏‎ (2 revisions)
  24. Decay constant‏‎ (2 revisions)
  25. Self-help protection‏‎ (2 revisions)
  26. Individual-related‏‎ (2 revisions)
  27. Dose of record Hp (10)‏‎ (2 revisions)
  28. Electrophysiology‏‎ (2 revisions)
  29. Storage‏‎ (2 revisions)
  30. Transfer compartment‏‎ (2 revisions)
  31. Mitigation‏‎ (2 revisions)
  32. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  33. Action Level‏‎ (2 revisions)
  34. Upper reference levels‏‎ (2 revisions)
  35. Neurovascular syndrome‏‎ (2 revisions)
  36. Health Surveillance‏‎ (2 revisions)
  37. Pelagic‏‎ (2 revisions)
  38. Basal cell‏‎ (2 revisions)
  39. Practical radiological protection culture‏‎ (2 revisions)
  40. Branching fraction‏‎ (2 revisions)
  41. Chronic exposure‏‎ (2 revisions)
  42. Radioactive source‏‎ (2 revisions)
  43. Colony‏‎ (2 revisions)
  44. Cosmic Radiation in Aviation‏‎ (2 revisions)
  45. Decommissioning‏‎ (2 revisions)
  46. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  47. Dose-threshold‏‎ (2 revisions)
  48. Individual decontamination‏‎ (2 revisions)
  49. Subcutaneous tissue‏‎ (2 revisions)
  50. Low dose rate‏‎ (2 revisions)
  51. Exposure, external or internal‏‎ (2 revisions)
  52. Graft vs host disease‏‎ (2 revisions)
  53. Air-kerma, incident‏‎ (2 revisions)
  54. Heliosphere‏‎ (2 revisions)
  55. Qualified expert‏‎ (2 revisions)
  56. Class SR-0 gases‏‎ (2 revisions)
  57. Radioactive substance‏‎ (2 revisions)
  58. Reference biokinetic model‏‎ (2 revisions)
  59. Decontamination‏‎ (2 revisions)
  60. Relocation‏‎ (2 revisions)
  61. Diastasis‏‎ (2 revisions)
  62. Risk coefficient‏‎ (2 revisions)
  63. Individual monitoring‏‎ (2 revisions)
  64. Dose per unit intake coefficient‏‎ (2 revisions)
  65. Source term‏‎ (2 revisions)
  66. Emergency‏‎ (2 revisions)
  67. Latent time/period or latency interval‏‎ (2 revisions)
  68. Low level waste‏‎ (2 revisions)
  69. Exposure (in the context of inhalation)‏‎ (2 revisions)
  70. Transfer rate‏‎ (2 revisions)
  71. Multi-detector computed tomography‏‎ (2 revisions)
  72. Fractionation and dose delivery patterns‏‎ (2 revisions)
  73. Percutaneous coronary intervention‏‎ (2 revisions)
  74. Prevailing circumstances‏‎ (2 revisions)
  75. Broad beam therapy irradiation technique‏‎ (2 revisions)
  76. Class SR-1 gases‏‎ (2 revisions)
  77. Committed effective dose‏‎ (2 revisions)
  78. Radon Recommendations for Authorities‏‎ (2 revisions)
  79. Cost-benefit analysis‏‎ (2 revisions)
  80. Reference individual‏‎ (2 revisions)
  81. Decontamination factor‏‎ (2 revisions)
  82. Remedial action‏‎ (2 revisions)
  83. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  84. Dose rate‏‎ (2 revisions)
  85. Intervention Level‏‎ (2 revisions)
  86. Emergency exposure situation‏‎ (2 revisions)
  87. Substantial radiation dose level‏‎ (2 revisions)
  88. Erythropoietin‏‎ (2 revisions)
  89. ALARA‏‎ (2 revisions)
  90. Transforming growth factor‏‎ (2 revisions)
  91. Hierarchical tissues‏‎ (2 revisions)
  92. Area monitoring‏‎ (2 revisions)
  93. Pericarditis‏‎ (2 revisions)
  94. Benthic‏‎ (2 revisions)
  95. Principle of application of dose limits‏‎ (2 revisions)
  96. Bronchial region‏‎ (2 revisions)
  97. Class SR-2 gases‏‎ (2 revisions)
  98. Radioactivity‏‎ (2 revisions)
  99. Committed equivalent dose‏‎ (2 revisions)
  100. Radon Recommendations for Workplaces‏‎ (2 revisions)
  101. Reference level‏‎ (2 revisions)
  102. Remediation‏‎ (2 revisions)
  103. Dichotomous‏‎ (2 revisions)
  104. Risk of Exposure to Radon‏‎ (2 revisions)
  105. Dose rate effectiveness factor‏‎ (2 revisions)
  106. South Atlantic anomaly‏‎ (2 revisions)
  107. Interventional procedure‏‎ (2 revisions)
  108. Emergency plan‏‎ (2 revisions)
  109. Ethics‏‎ (2 revisions)
  110. Lymphatic system‏‎ (2 revisions)
  111. Multiplicative risk projection model‏‎ (2 revisions)
  112. Activity‏‎ (2 revisions)
  113. High level waste‏‎ (2 revisions)
  114. Clearance‏‎ (2 revisions)
  115. Deontological Ethics‏‎ (2 revisions)
  116. Repopulation‏‎ (2 revisions)
  117. Differentiation‏‎ (2 revisions)
  118. Routine monitoring‏‎ (2 revisions)
  119. ICRPædia Guide to Radon‏‎ (2 revisions)
  120. Special (non-routine) monitoring‏‎ (2 revisions)
  121. Lifetime risk‏‎ (2 revisions)
  122. Macrophage colony stimulating factor‏‎ (2 revisions)
  123. Beta-minus decay‏‎ (2 revisions)
  124. Clearance level‏‎ (2 revisions)
  125. Radiographer‏‎ (2 revisions)
  126. Representative organism (non-human biota)‏‎ (2 revisions)
  127. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  128. Dose constraint‏‎ (2 revisions)
  129. Early normal tissue responses‏‎ (2 revisions)
  130. Threshold dose for tissue reactions‏‎ (2 revisions)
  131. Magnetosphere‏‎ (2 revisions)
  132. Exposure situation‏‎ (2 revisions)
  133. Transmission detection system‏‎ (2 revisions)
  134. Multistage tumorigenesis‏‎ (2 revisions)
  135. Non-sphericity parameter‏‎ (2 revisions)
  136. Growth factor‏‎ (2 revisions)
  137. Alimentary tract transfer factor‏‎ (2 revisions)
  138. Pharynx‏‎ (2 revisions)
  139. Beta-plus decay‏‎ (2 revisions)
  140. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  141. Cumulative dose‏‎ (2 revisions)
  142. Representative person‏‎ (2 revisions)
  143. Safety‏‎ (2 revisions)
  144. Dose conversion coefficient‏‎ (2 revisions)
  145. Edema‏‎ (2 revisions)
  146. Specific effective energy‏‎ (2 revisions)
  147. Limitation of dose‏‎ (2 revisions)
  148. Excess relative risk‏‎ (2 revisions)
  149. Marrow cellularity‏‎ (1 revision)
  150. Multitarget equation‏‎ (1 revision)
  151. Acute exposure‏‎ (1 revision)
  152. Allometry‏‎ (1 revision)
  153. Pilomatricoma‏‎ (1 revision)
  154. ICRP Publication 102‏‎ (1 revision)
  155. ICRP Publication 116‏‎ (1 revision)
  156. Radiation-induced secondary malignancy‏‎ (1 revision)
  157. ICRP Publication 130‏‎ (1 revision)
  158. Radiological attack‏‎ (1 revision)
  159. ICRP Publication 145‏‎ (1 revision)
  160. Reactive oxygen species‏‎ (1 revision)
  161. ICRP Publication 2‏‎ (1 revision)
  162. Reference worker‏‎ (1 revision)
  163. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  164. Derived consideration reference level‏‎ (1 revision)
  165. ICRP Publication 92‏‎ (1 revision)
  166. ICRP Publication 40‏‎ (1 revision)
  167. ICRP Publication 55‏‎ (1 revision)
  168. Dose conversion convention‏‎ (1 revision)
  169. Informed consent‏‎ (1 revision)
  170. ICRP Publication 7‏‎ (1 revision)
  171. Spongiosa‏‎ (1 revision)
  172. ICRP Publication 84‏‎ (1 revision)
  173. Exclusion‏‎ (1 revision)
  174. Time-resolved computed tomography‏‎ (1 revision)
  175. Mutation component‏‎ (1 revision)
  176. Waste management‏‎ (1 revision)
  177. Normal tissue complication probability‏‎ (1 revision)
  178. Biological half-life‏‎ (1 revision)
  179. ICRP Publication 117‏‎ (1 revision)
  180. ICRP Publication 131‏‎ (1 revision)
  181. Radiological controlled area‏‎ (1 revision)
  182. ICRP Publication 146‏‎ (1 revision)
  183. Concentration ratio‏‎ (1 revision)
  184. ICRP Publication 20‏‎ (1 revision)
  185. Referrer‏‎ (1 revision)
  186. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  187. Derived investigation level‏‎ (1 revision)
  188. ICRP Publication 93‏‎ (1 revision)
  189. ICRP Publication 41‏‎ (1 revision)
  190. Directional dose equivalent‏‎ (1 revision)
  191. ICRU 4-element tissue‏‎ (1 revision)
  192. ICRP Publication 56‏‎ (1 revision)
  193. Dose conversion factor‏‎ (1 revision)
  194. ICRP Publication 70‏‎ (1 revision)
  195. Effect modifier‏‎ (1 revision)
  196. ICRP Publication 85‏‎ (1 revision)
  197. Endosteum‏‎ (1 revision)
  198. System of radiological protection‏‎ (1 revision)
  199. Treatment preparation in radiotherapy‏‎ (1 revision)
  200. Notification value‏‎ (1 revision)
  201. Other (systemic) tissues‏‎ (1 revision)
  202. Human Alimentary Tract Model‏‎ (1 revision)
  203. ICRP Publication 104‏‎ (1 revision)
  204. Biomarker‏‎ (1 revision)
  205. ICRP Publication 132‏‎ (1 revision)
  206. Clonogenic surviving fraction‏‎ (1 revision)
  207. ICRP Publication 147‏‎ (1 revision)
  208. Cone beam computed tomography‏‎ (1 revision)
  209. ICRP Publication 21‏‎ (1 revision)
  210. Region‏‎ (1 revision)
  211. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  212. Derived limit‏‎ (1 revision)
  213. ICRP Publication 94‏‎ (1 revision)
  214. ICRP Publication 42‏‎ (1 revision)
  215. ICRU sphere‏‎ (1 revision)
  216. ICRP Publication 57‏‎ (1 revision)
  217. ICRP Publication 71‏‎ (1 revision)
  218. ICRP Publication 86‏‎ (1 revision)
  219. Mean glandular dose‏‎ (1 revision)
  220. Absorption Type‏‎ (1 revision - redirect page)
  221. Trophic level‏‎ (1 revision)
  222. Additional dose‏‎ (1 revision)
  223. Nuclear medicine‏‎ (1 revision)
  224. Ambient dose equivalent‏‎ (1 revision)
  225. Human Respiratory Tract Model‏‎ (1 revision)
  226. Automatic exposure control‏‎ (1 revision)
  227. Pooled analysis‏‎ (1 revision)
  228. ICRP Publication 105‏‎ (1 revision)
  229. ICRP Publication 119‏‎ (1 revision)
  230. Radiation risk‏‎ (1 revision)
  231. ICRP Publication 133‏‎ (1 revision)
  232. ICRP Publication 148‏‎ (1 revision)
  233. ICRP Publication 22‏‎ (1 revision)
  234. Regional diagnostic reference levels‏‎ (1 revision)
  235. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  236. Derived reference level‏‎ (1 revision)
  237. ICRP Publication 95‏‎ (1 revision)
  238. ICRP Publication 43‏‎ (1 revision)
  239. Disposal facility‏‎ (1 revision)
  240. Sealed source‏‎ (1 revision)
  241. ICRP Publication 58‏‎ (1 revision)
  242. Solar flare‏‎ (1 revision)
  243. ICRP Publication 72‏‎ (1 revision)
  244. ICRP Publication 87‏‎ (1 revision)
  245. Linear dose response‏‎ (1 revision)
  246. 1928 Recommendations‏‎ (1 revision)
  247. Tissue reaction‏‎ (1 revision)
  248. Measured quantity‏‎ (1 revision)
  249. Tumour suppressor gene‏‎ (1 revision)
  250. National DRL‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:MostRevisions"